Chemotherapy of malignant melanoma
- 1 May 1979
- journal article
- Published by Wiley in World Journal of Surgery
- Vol. 3 (3) , 321-327
- https://doi.org/10.1007/bf01556584
Abstract
A number of drugs are being used in chemotherapy treatment programs of advanced melanoma. Of these, DTIC is the most important drug currently in use, producing a response rate of about 20% when used as a single agent. Studies with nitrosoureas report response rates ranging from 6 to 41%, with an average of 24%. Combinations of these 2 agents and other drugs have not yet shown a significant improvement in response over either drug used alone. However, several studies of chemo‐immunotherapy have reported overall response rates in the vicinity of 28%, somewhat higher than that obtained with chemotherapy alone.Keywords
This publication has 19 references indexed in Scilit:
- Results with methyl-CCNU and DTIC in metastatic melanomaCancer, 1977
- Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanomaCancer, 1977
- Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanomaCancer, 1977
- Combination chemotherapy of malignant melanoma with imidazole carboxamide, BCNU and vincristineCancer, 1976
- Clinical comparison of adriamycin and a combination of methyl‐CCNU and imidazole carboxamide in disseminated malignant melanomaClinical Pharmacology & Therapeutics, 1976
- Polychemotherapie des metastasierenden MelanomsDeutsche Medizinische Wochenschrift (1946), 1976
- Results of a randomized study comparing DTIC with TIC mustard in malignant melanomaCancer, 1976
- Comparison of the combination of 1, 3-bis(2-chloroethyl)-l-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-l-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanomaCancer, 1975
- A clinical trial of procarbazine plus vincristine plus bis‐chloroethyl‐nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanomaMedical and Pediatric Oncology, 1975
- Chemotherapy of malignant melanomaCancer, 1972